Quick Facts
Every Company has raised $55 million in Series D funding to scale its precision-fermented egg protein production.
The startup uses microbial fermentation to create functional egg proteins that can replace conventional animal-derived egg ingredients.
Its proteins are now being introduced in consumer products sold at major U.S. retail chains, including Walmart, signaling a shift to large-scale commercialization.
The ingredients are positioned as stable and cost-predictable alternatives amid volatility in global egg supply caused by avian flu disruptions and agricultural inflation.
Every Company reports producing its proteins at metric-ton monthly volumes, supporting use cases across baking, beverages and foodservice manufacturing.
The funding will be used to expand fermentation capacity, grow commercial partnerships and further refine protein functional performance for industrial applications.
The company is targeting the global egg market estimated at more than $270 billion annually, with a focus on ingredient-grade formulations rather than consumer-branded products.
Investors view the company as part of a broader shift toward scalable bio-manufacturing platforms that reduce reliance on livestock-based protein supply chains.